Return to search results.
Complete title: RTOG 0926 A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
|Research Study Number||7684|
|Principal Investigator||George Laramore, MD, PhD|
Research Study Description
PURPOSE: This phase II trial is studying how well radiation therapy given together with chemotherapy works in treating patients with stage I bladder cancer.
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Bladder Cancer; Solid Tumors; Urogenital Neoplasms
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.